In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
[audio:https://www.audiomedica.com/podcasting/aha2005/Milton_Packer.mp3]
Aggressive Statins: the IDEAL Treatment 17 Nov, 2005 MRI Scans Expand Therapeutic Window for Thrombolysis in Stroke 8 Feb, 2007 Blood Pressure, Cholesterol, Smoking: Key Factors in New European Guidelines to Prevent Heart Disease 5 Sep, 2007 
Hydrochlorothiazide: Not Recommended For First-Line Therapy In Hypertension 18 Jun, 2009 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014